These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36724936)

  • 1. RBF Protein with MA103 Adjuvant Elicited Protective Immunity against Human Respiratory Syncytial Virus in BALB/c Mice.
    Fang Q; Li H; Ren H; Cao L; Hu H; Zhang Y; Xu W
    Jpn J Infect Dis; 2023 May; 76(3):183-190. PubMed ID: 36724936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.
    Li H; Ren H; Zhou Y; Zhang Y; Cao L; Xu W
    PLoS One; 2022; 17(1):e0262231. PubMed ID: 35100303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection.
    Li H; Ren H; Zhang Y; Cao L; Xu W
    Sci Rep; 2021 Sep; 11(1):18641. PubMed ID: 34545126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Li H; Cao L; Zhang Y; Ren H; Zhao P; Xu W
    Arch Virol; 2020 May; 165(5):1057-1067. PubMed ID: 32144542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and application of a lethal model of an HRSV-long variant strain in BALB/c mice.
    Li H; Ren H; Cao L; Guo J; Song J; Zhang Y; Xu W
    Exp Anim; 2022 Nov; 71(4):500-509. PubMed ID: 35732419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus.
    Hu B; Jiang J; Zhan J; Li G; Jiang Y; Guan X; Chen Y; Fang Z
    Virol J; 2014 Aug; 11():142. PubMed ID: 25107552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice.
    Li H; Ren H; Cao L; Guo J; Zhang Y; Fang Q; Xu W
    Biochem Biophys Res Commun; 2022 Aug; 618():54-60. PubMed ID: 35716595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
    Ren H; Li H; Cao L; Wang Z; Zhou Y; Guo J; Zhang Y; Liu H; Xu W
    Vaccine; 2022 Nov; 40(47):6830-6838. PubMed ID: 36253219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
    Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
    J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
    J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12.
    Hancock GE; Smith JD; Heers KM
    Viral Immunol; 2000; 13(1):57-72. PubMed ID: 10733169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice.
    Singh SR; Dennis VA; Carter CL; Pillai SR; Moore EG
    Viral Immunol; 2007; 20(2):261-75. PubMed ID: 17603843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.
    Menon I; Kang SM; Braz Gomes K; Uddin MN; D'Souza M
    Vaccine; 2023 Feb; 41(6):1209-1222. PubMed ID: 36631361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
    Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
    Front Immunol; 2020; 11():1673. PubMed ID: 32849580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine.
    Klinguer-Hamour C; Libon C; Plotnicky-Gilquin H; Bussat MC; Revy L; Nguyen T; Bonnefoy JY; Corvaïa N; Beck A
    Vaccine; 2002 Jun; 20(21-22):2743-51. PubMed ID: 12034101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
    J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines.
    Bukreyev A; Whitehead SS; Prussin C; Murphy BR; Collins PL
    J Virol; 2000 Aug; 74(15):7151-7. PubMed ID: 10888656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.